Biotech

All Articles

Daiichi pays Merck $170M to develop lung cancer T-cell engager pact

.Merck &amp Co. has promptly made back a few of the prices of its Javelin Therapeutics purchase, dra...

BioMarin halts preclinical genetics therapy for heart condition

.After BioMarin conducted a springtime tidy of its own pipeline in April, the company has actually d...

Eisai vegetations molecular adhesive SEED along with $1.5 B biobucks handle

.Big Pharmas continue to be stuck to the concept of molecular adhesive degraders. The current compan...

Life science credit company reveals with $600M

.A brand-new worldwide life scientific research credit report firm, referred to as Symbiotic Capital...

BMS trenches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing yet another large bet from the Caforio age, terminating an offer for ...

Nuvation standstills wager inhibitor after taking into consideration stage 1 information

.After checking out at period 1 information, Nuvation Biography has actually decided to stop work wi...

' Scientific intuition' led FDA specialists to back Zevra's rare disease med

.Zevra Rehabs' rare condition medicine seems to become on the road to permission this loss after obt...

Pfizer takes $230M reached after axing neglected DMD gene treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has actually gone ...

AC Immune finds 'site' potential in Alzheimer's drug records

.After much more than 20 years of deal with neurodegenerative conditions, Swiss biotech AC Immune in...

GSK falls ph. 2 HPV vaccine over lack of best-in-class potential

.GSK has ditched a phase 2 individual papillomavirus (HPV) vaccination coming from its pipe after de...